U.S. generic drug market Archives - CDR

Health systems to form generic drug company

January 19, 2018 by CDR Blog and Chain Drug Review Anthony Tersigni, Ascension, Carolyn Clancy, Don Berwick, Intermountain Healthcare, Laura Kaiser, Marc Harrison, nonprofit generic drug company, Richard Gilfillan, SSM Health, Trinity Health, U.S. Department of Veterans Affairs, U.S. generic drug market CDR Blog

Fed up with high costs and supply shortfalls, several health care systems are banding together to form a nonprofit generic drug company. The health systems — Intermountain Healthcare, Ascension, SSM Health and Trinity Health, in consultation with the U.S. Department of Veterans Affairs — said the new company will make key generic medications more available and

Hikma to buy Roxane for $2.65 billion

July 31, 2015 by Chain Drug Review Andreas Barner, Boehringer Ingelheim, generic pharmaceuticals, Hikma Pharmaceuticals, Michael Raya, Roxane Laboratories, Said Darwazah, U.S. generic drug market, West-Ward Pharmacy, Supplier News

LONDON — Hikma Pharmaceuticals PLC, a fast growing multinational pharmaceutical group, plans to acquire Roxane Laboratories from Boehringer Ingelheim in a deal valued at $2.65 billion. Hikma said the agreement stands to transform its position in the U.S. generic drug market, establishing the company as the sixth-largest generics maker by revenue. The addition of Roxane